TNFRSF9 and neoplasm: The aim of this paper is to present the following medical hypothesis: CD137 and Eomes constitute a specific T cell activating axis, which results in the reprogramming of TREG into effector CD4 + FoxP3 + T cells and the tumor-specific activation of CD8 + T cells.